======= KIF15 ======= == Gene Information == * **Official Symbol**: KIF15 * **Official Name**: kinesin family member 15 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=56992|56992]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9NS87|Q9NS87]] * **Interactions**: [[https://thebiogrid.org/search.php?search=KIF15&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20KIF15|Open PubMed]] * **OMIM**: [[https://omim.org/entry/617569|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Plus-end directed kinesin-like motor enzyme involved in mitotic spindle assembly. {ECO:0000250}. |Kinesin-relat 1| |Kinesin| |plus-end kinesin complex| |motor activity| |kinesin complex| |microtubule motor activity| |retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum| |antigen processing and presentation of exogenous peptide antigen via MHC class II| |antigen processing and presentation of peptide antigen via MHC class II| |antigen processing and presentation of peptide or polysaccharide antigen via MHC class II| |spindle| |antigen processing and presentation of exogenous peptide antigen| |antigen processing and presentation of exogenous antigen| |antigen processing and presentation of peptide antigen| |antigen processing and presentation| |ATPase activity| |microtubule binding| |microtubule-based movement| |microtubule| |Golgi vesicle transport| |centrosome| |microtubule-based process| |mitotic cell cycle| |cell cycle| |ATP binding| |movement of cell or subcellular component| |vesicle-mediated transport| |membrane| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp228|Demecolcine 0.03μM R05 exp228]]|-5.67| |[[:results:exp215|Colchicine 0.009μM R05 exp215]]|-5.11| |[[:results:exp243|S-trityl-L-cysteine 0.5μM R05 exp243]]|-4.43| |[[:results:exp60|Vinblastine 0.002μM R01 exp60]]|-3.53| |[[:results:exp460|BML-284 0.09μM R08 exp460]]|-3.31| |[[:results:exp190|Vincristine 0.0005μM R04 exp190]]|-3.22| |[[:results:exp179|Combretastatin A4 0.002 to 0.003μM day4 R04 exp179]]|-3.16| |[[:results:exp97|BI-6727 0.0125μM R03 exp97]]|-3.09| |[[:results:exp95|BI-2536 0.0042μM R03 exp95]]|-2.9| |[[:results:exp529|Thimerosal 0.85μM R08 exp529]]|-2.75| |[[:results:exp125|GSK461364A 0.005μM R03 exp125]]|-2.61| |[[:results:exp184|Ixabepilone 0.004 to 0.005μM on day4 R04 exp184]]|-2.34| |[[:results:exp217|Mdivi-1 15μM R05 exp217]]|-2.27| |[[:results:exp525|Sulforaphane 9μM R08 exp525]]|-1.8| |[[:results:exp103|Taxol 0.004μM R03 exp103]]|-1.72| ^Gene^Correlation^ |[[:human genes:d:dlgap5|DLGAP5]]|0.625| |[[:human genes:m:mapre1|MAPRE1]]|0.536| |[[:human genes:t:tacc3|TACC3]]|0.531| |[[:human genes:a:aspm|ASPM]]|0.456| |[[:human genes:g:gsg2|GSG2]]|0.439| |[[:human genes:l:lrrc8a|LRRC8A]]|0.421| |[[:human genes:k:klf16|KLF16]]|0.412| |[[:human genes:k:kif18a|KIF18A]]|0.403| |[[:human genes:v:vbp1|VBP1]]|0.401| Global Fraction of Cell Lines Where Essential: 3/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|3/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 13163 * **Expression level (log2 read counts)**: 6.61 {{:chemogenomics:nalm6 dist.png?nolink |}}